AJR Am J Roentgenol

1. DABIRI BE
   Editorial Comment: Ablation for Early-Stage Hepatocellular Carcinoma Results in Lower Costs Relative to Both Surgical Resection and Transplant.
   AJR Am J Roentgenol. 2024 Jul 17. doi: 10.2214/AJR.24.31657.
   

   >> Share

   
   
2. CAO JJ, Shen L, Yoon L, Kamaya A, et al
   Differentiation of Hepatocellular Adenoma Subtypes and Focal Nodular Hyperplasia on Gadoxetate Disodium-Enhanced MRI: An Updated Diagnostic Algorithm.
   AJR Am J Roentgenol. 2024 Jul 17. doi: 10.2214/AJR.24.31628.
   

   >> Share

   
   

   
   Am J Gastroenterol

3. TAPPER EB, Goldberg D, Parikh ND, Terrault NA, et al
   The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.
   Am J Gastroenterol. 2024 Jul 17. doi: 10.14309/ajg.0000000000002953.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

4. CHEN Y, Zhang Y, Jin X, Hong S, et al
   Exerkines: Benign adaptation for exercise and benefits for non-alcoholic fatty liver disease.
   Biochem Biophys Res Commun. 2024;726:150305.
   

   >> Share

   
   
5. YU T, Wang L, Cheng Y, Zhang Y, et al
   Downregulation of Setdb2 promotes alternative activation of macrophages via the PI3K/Akt pathway to attenuate NAFLD after sleeve gastrectomy.
   Biochem Biophys Res Commun. 2024;726:150264.
   

   >> Share

   
   
6. GWON HJ, Chung YH, Lim DS, Cho W, et al
   Uvaol ameliorates lipid deposition in hyperlipidemic hepatocytes by suppressing protein-tyrosine phosphatase 1B/ER stress signaling.
   Biochem Biophys Res Commun. 2024;730:150387.
   

   >> Share

   
   

   
   BMC Cancer

7. CHENG Q, Ji W, Lv Z, Wang W, et al
   Comprehensive analysis of PHF5A as a potential prognostic biomarker and therapeutic target across cancers and in hepatocellular carcinoma.
   BMC Cancer. 2024;24:868.
   

   >> Share

   
   
8. KY TD, Loan NT, Thinh NT, Binh MT, et al
   Nonadherence to oral cancer chemotherapy in hepatocellular carcinoma: prevalence and predictive factors in Vietnam.
   BMC Cancer. 2024;24:841.
   

   >> Share

   
   

   
   BMC Gastroenterol

9. ELHOSEENY MM, Abdulaziz BA, Mohamed MA, Elsharaby RM, et al
   Fetuin-A: a relevant novel serum biomarker for non-invasive diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective case-control study.
   BMC Gastroenterol. 2024;24:226.
   

   >> Share

   
   
10. SHI Y, Feng W, Cai J, Wang Z, et al
    Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study.
    BMC Gastroenterol. 2024;24:224.
    

    >> Share

    
    

    
    Br J Surg

11. BAHRI S, Brown L, Perin G, Balasubramanian SP, et al
    Comment on: Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial.
    Br J Surg. 2024;111:znae171.
    

    >> Share

    
    

    
    Cancer

12. SPUNT SL, Xue W, Gao Z, Hayes Dixon A, et al
    Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332.
    Cancer. 2024;130:2683-2693.
    

    >> Share

    
    
13. AWAD A, Pal K, Yevich S, Kuban JD, et al
    Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver.
    Cancer. 2024;130:2703-2712.
    

    >> Share

    
    
14. VAN NOESEL MM
    Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver.
    Cancer. 2024;130:2582-2585.
    

    >> Share

    
    

    
    Dig Dis Sci

15. STERN C, Ngo A, Villela-Nogueira C, Thabut D, et al
    A Simple and Reliable 2D-Shear Wave Elastography and UltraSound Coefficient Attenuation Parameter Technique in Chronic Liver Diseases.
    Dig Dis Sci. 2024;69:2648-2654.
    

    >> Share

    
    

    
    Endoscopy

16. MARTINEZ-MORENO B, Martinez Martinez J, Herrera I, Guilabert L, et al
    Correlation of EUS-guided portal pressure gradient measurements with hepatic venous pressure gradient: a prospective study.
    Endoscopy. 2024 Jul 18. doi: 10.1055/a-2369-0759.
    

    >> Share

    
    

    
    Eur Radiol

17. POETTER-LANG S, Ambros R, Messner A, Kristic A, et al
    Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid-enhanced MRI? A large-cohort study.
    Eur Radiol. 2024;34:5215-5227.
    

    >> Share

    
    
18. GROSS M, Huber S, Arora S, Ze'evi T, et al
    Automated MRI liver segmentation for anatomical segmentation, liver volumetry, and the extraction of radiomics.
    Eur Radiol. 2024;34:5056-5065.
    

    >> Share

    
    

    
    Gastrointest Endosc

19. TEPOX-PADRON A, Mohamed R, Li S
    Coil migration into the pulmonary artery after gastric variceal EUS-guided coil embolization.
    Gastrointest Endosc. 2024;100:330-332.
    

    >> Share

    
    

    
    Hepatology

20. BERENGUER J, Bellon JM, Banares R, Gonzalez-Garcia J, et al
    Reply: Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis.
    Hepatology. 2024 Jun 20. doi: 10.1097/HEP.0000000000000977.
    

    >> Share

    
    
21. 
    Diagnosis and Management of Hepatocellular Carcinoma.
    Hepatology. 2024 Jul 17. doi: 10.1097/HEP.0000000000001010.
    

    >> Share

    
    
22. CELSA C, Cabibbo G, Fulgenzi CAM, Battaglia S, et al
    Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
    Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001026.
    

    >> Share

    
    
23. JEONG JM, Choi SE, Shim YR, Kim HH, et al
    CX3CR1+ macrophages interact with hepatic stellate cells to promote hepatocellular carcinoma through CD8+ T cell suppression.
    Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001021.
    

    >> Share

    
    
24. HLADY RA, Robertson KD
    Epigenetic memory of environmental exposures as a mediator of liver disease.
    Hepatology. 2024;80:451-464.
    

    >> Share

    
    
25. YANG D, Tian T, Li X, Zhang B, et al
    ZNT1 and Zn 2+ control TLR4 and PD-L1 endocytosis in macrophages to improve chemotherapy efficacy against liver tumor.
    Hepatology. 2024;80:312-329.
    

    >> Share

    
    
26. WANG Q, Bu Q, Pan B, Yin Y, et al
    Letter to the Editor: Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury.
    Hepatology. 2024;80:E24-E25.
    

    >> Share

    
    
27. JEPSEN P, West J, Kann AE, Kraglund F, et al
    Risk of alcohol-associated liver disease in the offspring of parents with alcohol-associated liver disease: A nationwide cohort study.
    Hepatology. 2024;80:418-427.
    

    >> Share

    
    
28. RAMAN KP, Patch D
    Tranexamic acid in variceal bleeding revisited.
    Hepatology. 2024;80:257-259.
    

    >> Share

    
    
29. GARCIA-TSAO G, Kaplan DE
    Reply: Endoscopy for potential variceal bleeding within 12 hours-Not so fast!
    Hepatology. 2024;80:E36.
    

    >> Share

    
    
30. 
    Hepatology Highlights.
    Hepatology. 2024;80:255-256.
    

    >> Share

    
    
31. 
    August Hepatology Highlights.
    Hepatology. 2023;78:369-370.
    

    >> Share

    
    

    
    Indian J Gastroenterol

32. ALEXANDER V, Chellaiya GK, Gnanadeepam S, David VG, et al
    On-treatment decline in MELD score predicts one-month transplant-free survival in rodenticidal hepatotoxicity patients treated with low-volume plasma exchange.
    Indian J Gastroenterol. 2024 Jul 13. doi: 10.1007/s12664-024-01585.
    

    >> Share

    
    

    
    Int J Cancer

33. VAZ J, Jepsen P, Stromberg U, Midlov P, et al
    Metabolic dysfunction-associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study.
    Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35097.
    

    >> Share

    
    

    
    J Gastroenterol

34. HAO Y, Hao Z, Zeng X, Lin Y, et al
    Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation.
    J Gastroenterol. 2024 Jul 19. doi: 10.1007/s00535-024-02134.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

35. CHU CS, Chen HP, Lin PH, Cheng CC, et al
    Interleukin-1 receptor 1 deficiency worsens hepatocellular carcinoma, while gemcitabine treatment alleviates the hepatocellular carcinoma-induced increase in intra-hepatic immune cells.
    J Gastroenterol Hepatol. 2024 Jul 15. doi: 10.1111/jgh.16674.
    

    >> Share

    
    

    
    J Hepatol

36. DI COLA S, D'Amico G, Merli M
    Reply to "Reevaluating Myosteatosis Criteria in Cirrhosis: Fluid and Gender Considerations ".
    J Hepatol. 2024 Jul 11:S0168-8278(24)02353-5. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    

    
    J Pediatr Surg

37. DAVENPORT M, Superina R
    Primary Liver Transplant in Biliary Atresia: The Case for and Against.
    J Pediatr Surg. 2024 Mar 14:S0022-3468(24)00156.
    

    >> Share

    
    

    
    Oncogene

38. ZHANG T, Zhao F, Hu Y, Wei J, et al
    Environmental monobutyl phthalate exposure promotes liver cancer via reprogrammed cholesterol metabolism and activation of the IRE1alpha-XBP1s pathway.
    Oncogene. 2024;43:2355-2370.
    

    >> Share

    
    
39. LI W, Guo Z, Zhou Z, Zhou Z, et al
    Distinguishing high-metastasis-potential circulating tumor cells through fluidic shear stress in a bloodstream-like microfluidic circulatory system.
    Oncogene. 2024;43:2295-2306.
    

    >> Share

    
    

    
    Semin Liver Dis

40. WERNER W, Kuzminskaya M, Lurje I, Tacke F, et al
    Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
    Semin Liver Dis. 2024;44:159-179.
    

    >> Share

    
    
41. FISCHER AM, Lechea N, Coxson HO
    This Is What Metabolic Dysfunction-Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol.
    Semin Liver Dis. 2024;44:226-238.
    

    >> Share

    
    
42. LI CC, Liu M, Lee HP, Wu W, et al
    Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives.
    Semin Liver Dis. 2024;44:133-146.
    

    >> Share

    
    
43. PHAM N, Benhammou JN
    Statins in Chronic Liver Disease: Review of the Literature and Future Role.
    Semin Liver Dis. 2024;44:191-208.
    

    >> Share

    
    
44. FUJIWARA N, Kimura G, Nakagawa H
    Emerging Roles of Spatial Transcriptomics in Liver Research.
    Semin Liver Dis. 2024;44:115-132.
    

    >> Share

    
    

    
    Transplant Proc

45. THULUVATH AJ, Kim M, Peipert J, Duarte-Rojo A, et al
    Patient-Reported Outcome Screens for Cognitive Dysfunction and Predicts Admissions in Cirrhosis.
    Transplant Proc. 2024 Jul 17:S0041-1345(24)00326.
    

    >> Share

    
    
46. WANG N, Zhu Z, Zheng H, Qi C, et al
    Diagnosis and Treatment of Hepatic Hematoma After Liver Transplantation in a Timely Manner.
    Transplant Proc. 2024 Jul 13:S0041-1345(24)00343.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share